Kyorin Pharmaceutical Co Ltd 2024 Integrated Report
Company: Kyorin Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2024
Type: Integrated Report
Pages: 52
The report describes Kyorin Group's FY2023 integrated reporting period following its 100th-anniversary reorganization into a business holding company. It reports consolidated net sales of ¥119,532 million and highlights the Takaoka Plant's commencement in April 2024. Sustainability priorities include 10 materialities, a 46% Scope 1 + Scope 2 CO2 reduction target by fiscal 2030 from fiscal 2015, and carbon neutrality by 2050. Human-capital disclosures include 2,042 consolidated employees and initiatives to raise women's management representation.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.